Marta Saura Selected Research

1,1-diethyl-2-hydroxy-2-nitrosohydrazine

1/2016

Nitric Oxide Induces Cardiac Protection by Preventing Extracellular Matrix Degradation through the Complex Caveolin-3/EMMPRIN in Cardiac Myocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta Saura Research Topics

Disease

5	Ischemia 01/2022 - 01/2016
4	Necrosis 01/2022 - 07/2011
4	Myocardial Infarction 01/2022 - 01/2016
4	Atherosclerosis 10/2018 - 10/2006
3	Hypertension (High Blood Pressure) 01/2022 - 03/2011
3	Vascular Diseases (Vascular Disease) 03/2011 - 11/2005
2	Infarction (Infarctions) 01/2016 - 01/2016
2	Virus Diseases (Viral Diseases) 03/2007 - 12/2006
2	Coxsackievirus Infections 03/2007 - 12/2006
1	Edema (Dropsy) 01/2022
1	Hemorrhage 01/2022
1	Cardiogenic Shock 12/2021
1	Inflammation (Inflammations) 03/2021
1	familial dilated cardiomyopathy 01/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Atherosclerotic Plaque (Atheroma) 10/2018
1	Vascular Remodeling 01/2017
1	Reperfusion Injury 01/2016
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 08/2014
1	Neointima 08/2014
1	Hyperplasia 08/2014
1	Shock 02/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2011
1	Wounds and Injuries (Trauma) 09/2008

Drug/Important Bio-Agent (IBA)

8	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2022 - 07/2011
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018 - 10/2006
6	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 07/2011
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2006
3	IvabradineIBA 12/2021 - 09/2020
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2017 - 07/2011
2	GadoliniumIBA 01/2022 - 10/2018
2	Metalloproteases (Metalloproteinases)IBA 01/2022 - 10/2018
2	Peptides (Polypeptides)IBA 01/2022 - 10/2018
2	Messenger RNA (mRNA)IBA 12/2021 - 11/2014
2	Caveolin 3IBA 12/2021 - 01/2016
2	integrin-linked kinaseIBA 01/2017 - 02/2012
2	Peptide Hydrolases (Proteases)FDA Link 03/2007 - 12/2006
2	NF-KappaB Inhibitor alphaIBA 03/2007 - 12/2006
1	AlbuminsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CreatinineIBA 01/2022
1	CollagenIBA 01/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022
1	Cyclophilin AIBA 03/2021
1	LigandsIBA 03/2021
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 10/2018
1	GelatinasesIBA 01/2016
1	1,1-diethyl-2-hydroxy-2-nitrosohydrazineIBA 01/2016
1	Drinking WaterIBA 01/2016
1	Evans Blue (Blue, Evans)FDA Link 01/2016
1	Superoxides (Superoxide)IBA 11/2014
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2014
1	Angiotensin IIIBA 11/2014
1	bisphenol AIBA 11/2014
1	Peroxynitrous Acid (Peroxynitrite)IBA 11/2014
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 11/2014
1	Monocyte Chemoattractant ProteinsIBA 08/2014
1	AntigensIBA 08/2014
1	InterferonsIBA 08/2014
1	Interleukin-6 (Interleukin 6)IBA 08/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014
1	Interleukin-5 (Interleukin 5)IBA 08/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2014
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2012
1	Extracellular Matrix ProteinsIBA 03/2011
1	IntegrinsIBA 03/2011
1	Caveolin 1IBA 09/2008
1	Tyrosine (L-Tyrosine)FDA Link 09/2008
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2008
1	Matrix Metalloproteinase 13IBA 09/2008
1	NF-kappa B (NF-kB)IBA 03/2007
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2005

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 03/2011 - 02/2006
1	Precision Medicine 01/2022
1	Endarterectomy (Thromboendarterectomy) 10/2018
1	Ligation 01/2017
1	Oral Administration 11/2014